Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity-Reference-Cited by-同舟云学术

Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity

Published:2023-12-15 Issue:1 Volume:23 Page:88-101
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Colombo Laura¹^ORCID,Hadigal Sanjay²,Nauta Jos³,Kondratenko Alona⁴,Rogoll Jutta⁵,van de Witte Serge³

Affiliation:

1. Global Medical Affairs, Viatris, Monza, Italy

2. Global Medical Affairs, Viatris, Bengaluru, India

3. Innovation & Development, Abbott, Weesp, The Netherlands

4. Global Medical Affairs, Abbott, Allschwil, Switzerland

5. Global Pharmacovigilance, Abbott, Hannover, Germany

Funder

Viatris

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2293241

Reference60 articles.

1. World Health Organization. Vaccines against influenza: WHO position paper – May 2022: World Health Organization; 2022 [cited 2023 Apr 6]. Available from: https://www.who.int/publications/i/item/who-wer9719

2. World Health Organization. Influenza (Seasonal) 2023 [cited 2023 2 Jun]. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)

3. European Centre for Disease Prevention and Control. Factsheet about seasonal influenza. 2022 [cited 2022 Jul 26]. Available from: https://www.ecdc.europa.eu/en/seasonal-influenza/facts/factsheet

4. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

5. Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Syncytial Virus, Influenza and SARS-CoV-2 in Homeless People from Urban Shelters: A Systematic Review and Meta-Analysis (2023);Epidemiologia;2024-01-31